Internal Medicine and Pediatrics, 1092Albany Medical College, Albany Medical Center Internal Medicine and Pediatrics, Cohoes, NY, USA.
Management and Health Studies, Siena College, Loudonville, NY, USA.
Int J Health Serv. 2022 Jul;52(3):363-371. doi: 10.1177/00207314221100647. Epub 2022 May 12.
The process of developing and marketing new pharmaceuticals in the United States is driven by a need to maximize returns to shareholders. This results all too often in the production of new medications that are expensive and of marginal value to patients and society. In line with our heightened awareness of the importance of social justice and public health-and in light of our government's alliance with private companies in bringing us COVID-19 vaccines-we need to reconsider how new pharmaceuticals are developed and distributed. Accordingly, we propose the creation of a new agency of the Food and Drug Administration (FDA) that would direct the whole process. This agency would fund the research and development of high-value medications, closely monitor the clinical studies of these new drugs, and manage their distribution at prices that are value-based, fair, and equitable.
美国开发和营销新药的过程是由股东回报最大化的需求驱动的。这往往导致生产新的药物，这些药物对患者和社会来说是昂贵的，价值不大。为了与我们对社会正义和公共卫生的重要性的认识保持一致，并且鉴于我们的政府与私营公司合作，为我们带来了 COVID-19 疫苗，我们需要重新考虑新药的开发和分配方式。因此，我们建议创建一个新的食品和药物管理局（FDA）机构，负责指导整个过程。该机构将为高价值药物的研发提供资金，密切监测这些新药的临床研究，并以基于价值、公平和公正的价格管理其分配。
